Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 13, 2023 at 05:23 am EST
Share
Mega Lifesciences Public Company Limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was THB 3,829.92 million compared to THB 4,079.14 million a year ago. Net income was THB 535.55 million compared to THB 658.27 million a year ago. Basic earnings per share from continuing operations was THB 0.61 compared to THB 0.76 a year ago.
For the nine months, revenue was THB 11,587.14 million compared to THB 11,867.39 million a year ago. Net income was THB 1,519.49 million compared to THB 1,841.78 million a year ago. Basic earnings per share from continuing operations was THB 1.74 compared to THB 2.11 a year ago.
Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.